These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 34807468)
41. Facilitating COVID-19 Vaccination Among Caregivers of Children With Medical Complexity. Lakhaney D; Shaw E; Stockwell MS Clin Pediatr (Phila); 2021 Nov; 60(13):497-500. PubMed ID: 34706579 [No Abstract] [Full Text] [Related]
42. SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists. Priori R; Pellegrino G; Colafrancesco S; Alessandri C; Ceccarelli F; Di Franco M; Riccieri V; Scrivo R; Sili Scavalli A; Spinelli FR; Conti F Ann Rheum Dis; 2021 Jul; 80(7):953-954. PubMed ID: 33622689 [No Abstract] [Full Text] [Related]
43. Cutaneous composite small lymphocytic lymphoma and primary cutaneous follicle center lymphoma. Wang HY; Hinds BR Blood; 2019 Aug; 134(8):717. PubMed ID: 31439617 [No Abstract] [Full Text] [Related]
44. Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma. Tam CS; Wolf M; Prince HM; Januszewicz EH; Westerman D; Lin KI; Carney D; Seymour JF Cancer; 2006 Jun; 106(11):2412-20. PubMed ID: 16649223 [TBL] [Abstract][Full Text] [Related]
45. Are the conditions met to make COVID-19 vaccination mandatory for healthcare professionals? Gagneux-Brunon A; Botelho-Nevers E; Launay O Infect Dis Now; 2021 Sep; 51(6):507-509. PubMed ID: 34144228 [No Abstract] [Full Text] [Related]
46. Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Budziar W; Gembara K; Harhala M; Szymczak A; Jędruchniewicz N; Baniecki K; Pikies A; Nahorecki A; Hoffmann A; Kardaś A; Szewczyk-Dąbrowska A; Klimek T; Kaźmierczak Z; Witkiewicz W; Barczyk K; Dąbrowska K PLoS One; 2022; 17(2):e0253638. PubMed ID: 35113873 [TBL] [Abstract][Full Text] [Related]
47. Covid-19 vaccines for teenagers: conversations and consent. Saxena S; Skirrow H; Bedford H; Wighton K BMJ; 2021 Sep; 374():n2312. PubMed ID: 34551892 [No Abstract] [Full Text] [Related]
48. Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors. Terpos E; Zagouri F; Liontos M; Sklirou AD; Koutsoukos K; Markellos C; Briasoulis A; Papanagnou ED; Trougakos IP; Dimopoulos MA J Hematol Oncol; 2021 May; 14(1):86. PubMed ID: 34059088 [TBL] [Abstract][Full Text] [Related]
49. Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual. Ogai A; Yoshida R; Yuasa C; Chin K; Fujimaki K; Nakajima H Int J Hematol; 2022 Feb; 115(2):293-295. PubMed ID: 34716890 [No Abstract] [Full Text] [Related]
51. Severe aplastic anemia associated with paroxysmal nocturnal hemoglobinuria and lymphoplasmacytic lymphoma. Veidt RG; Ansari-Lari A; Brodsky RA Leuk Lymphoma; 2005 Aug; 46(8):1243-6. PubMed ID: 16085570 [TBL] [Abstract][Full Text] [Related]
52. Boosting the nation against covid-19: are the vaccination targets feasible? Osama T; Hodes S; Razai MS; Majeed A BMJ; 2021 Dec; 375():n3094. PubMed ID: 34911679 [No Abstract] [Full Text] [Related]
53. A Case of Long-Term SARS-CoV-2 Infection in a Patient with Follicular Lymphoma. Zhang D; Zheng Z Clin Lab; 2024 May; 70(5):. PubMed ID: 38747907 [No Abstract] [Full Text] [Related]